MyFinsight
Home
Blog
About
Contact
Back
Income Statement
ADIAL PHARMACEUTICALS, INC. (ADIL)
ADIAL PHARMACEUTICALS, INC. (ADIL)
source: myfinsight.com
Download
Download image
Net loss
-$2,022,392
(9.26%↑ Y/Y)
Loss from operations
-$2,001,481
(11.72%↑ Y/Y)
Total other income
(expense)
-$20,911
Interest income
$47,059
Total operating
expenses
$2,001,481
Losses from equity
method investment
-$67,970
General and
administrative expenses
$1,568,951
Research and development
expenses
$432,530
Back